Therefore, the current review firstly describes the mechanistic insights into the cholesterol homeostasis through HMG-R, PCSK-9, and LDL-R functionality and then compiles the cardioprotective effects of natural secondary metabolites with special emphasis on their dual HMG-R and PCSK-9 inhibitory action in ASCVD risk management. Here, PCSK9 is linked to atherosclerosis.